Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis C

Free Subscription Articles published in Scand J Gastroenterol Retrieve available abstracts of 17 articles: HTML format Text format

Single Articles

July 2019
1. WELLHONER F, Doscher N, Tergast TL, Vital M, et al
   The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients.
   Scand J Gastroenterol. 2019 Jul 30:1-9. doi: 10.1080/00365521.2019.1647280.
   PubMed     Text format     Abstract available
   
   
   May 2019
2. GAYAM V, Tiongson B, Mandal AK, Garlapati P, et al
   Real-world study of hepatitis C treatment with direct-acting antivirals in patients with drug abuse and opioid agonist therapy.
   Scand J Gastroenterol. 2019 May 23:1-10. doi: 10.1080/00365521.2019.1617893.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. KABERG M, Edgren E, Hammarberg A, Weiland O, et al
   Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity.
   Scand J Gastroenterol. 2019 Mar 23:1-9. doi: 10.1080/00365521.2019.1580764.
   PubMed     Text format     Abstract available
   
   
   January 2019
4. YUYUN D, Zhihua T, Haijun W, Zhaoping L, et al
   Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis.
   Scand J Gastroenterol. 2019;54:81-86.
   PubMed     Text format     Abstract available
   
   
   November 2018
5. KILENG H, Kjellin M, Akaberi D, Bergfors A, et al
   Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
   Scand J Gastroenterol. 2018 Nov 5:1-7. doi: 10.1080/00365521.2018.1511824.
   PubMed     Text format     Abstract available
   
   
   August 2018
6. PERRELLA A, Izzi A, Punzi R, Adinolfi E, et al
   Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?
   Scand J Gastroenterol. 2018;53:1025-1026.
   PubMed     Text format    
   
   
   July 2018
7. LUND LAURSEN T, Brockner Siggard C, Kazankov K, Damgaard Sandahl T, et al
   Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
   Scand J Gastroenterol. 2018 Jul 10:1-8. doi: 10.1080/00365521.2018.1481996.
   PubMed     Text format     Abstract available
   
   
   
8. ZUBKIN ML, Abdurakhmanov DT, Sagalova OI, Bakulin IG, et al
   Persistent mixed cryoglobulinemia after successful antiviral treatment of chronic hepatitis C virus infection: What's the next?
   Scand J Gastroenterol. 2018 Jul 2:1-2. doi: 10.1080/00365521.2018.1477988.
   PubMed     Text format    
   
   
   June 2018
9. MILLBOURN C, Psaros Einberg A, Lindh G, Hokeberg I, et al
   Prevalence and outcome of post-transfusion hepatitis C acquired at different ages and detected in look-back screening.
   Scand J Gastroenterol. 2018 Jun 18:1-6. doi: 10.1080/00365521.2018.1476911.
   PubMed     Text format     Abstract available
   
   
   May 2018
10. CARVALHO JR, Velosa J, Serejo F
    Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens.
    Scand J Gastroenterol. 2018 May 20:1-7. doi: 10.1080/00365521.2018.1473486.
    PubMed     Text format     Abstract available
    
    
    
11. SOLUND C, Hallager S, Pedersen MS, Fahnoe U, et al
    Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.
    Scand J Gastroenterol. 2018 May 2:1-8. doi: 10.1080/00365521.2018.1467963.
    PubMed     Text format     Abstract available
    
    
    January 2018
12. BARTH C, Neusser S, Biermann J, Wasem J, et al
    Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
    Scand J Gastroenterol. 2018;53:76-82.
    PubMed     Text format     Abstract available
    
    
    October 2017
13. HANSEN JF, Juul Nielsen M, Nystrom K, Leeming DJ, et al
    PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.
    Scand J Gastroenterol. 2017 Oct 25:1-5. doi: 10.1080/00365521.2017.1392596.
    PubMed     Text format     Abstract available
    
    
    July 2017
14. 
    Correction to: Castedal et al., IFN-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
    Scand J Gastroenterol. 2017 Jul 13:1. doi: 10.1080/00365521.2017.1354499.
    PubMed     Text format    
    
    
    May 2017
15. MARIA C, Michael S, Susanne C, Catarina S, et al
    INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
    Scand J Gastroenterol. 2017;52:585-588.
    PubMed     Text format     Abstract available
    
    
    October 2016
16. ZHU H, Wu J, Shen X
    Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.
    Scand J Gastroenterol. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
17. MURUNGA E, Andersson M, Rensburg Cv
    Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?
    Scand J Gastroenterol. 2016;51:814-8.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: